Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 4, 2004, Pages 259-263

  Smith, Andrew ^a   Jackson, Margaret S ^a   Kennedy, Helen ^b  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC KIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; SPECIES DIFFERENCE; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; TEST STRIP;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 2642524393     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410019435     Document Type: Article

References (25)

1. Bourgault AM, Wilson WR, Washington JA. Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis 1979; 140: 316-24.
2. McWhinney PMH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother 1993; 37: 493-6.
3. Avada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteraemia in patients with cancer. Clin Infect Dis 1992; 15: 33-48.
4. Bochud PY, Engiman P, Calandra T, van Melle G, Saghafi L, Francioloi P. Bacteraemia due to viridans streptococci in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18: 25-31.
5. Alcaide F, Linares J, Pallares R, Carratala J, Benitez MA, Gudiol F, Martin R. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995; 39: 2243-7.
6. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-4.
7. Renneberg LL, Niemann LL, Gutschik E. Antimicrobial susceptibility of 278 streptococcal blood isolates to 7 antimicrobial agents. J Antimicrob Chemother 1997; 39: 135-40.
8. Teng LJ, Hsueh PR, Ho SW, Luh KT Antimicrobial susceptibility of viridans streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998; 41: 621-7.
9. Coffey TJ, Dowson CG, Daniels M, Spratt BG. Horizontal spread of an altered penicillin binding protein 2B gene between Streptococcus pneumoniae and Streptococcus oralis. FEMS Microbiol Lett 1993; 110: 335-40.
10. Van der Meer JTM, van Vianen W, Hu E, van Leeuwen WB, Valkenburg JA, Thompson J, Michel MF. Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture positive cases of endocarditis in the Netherlands. Euro J Clin Microbiol Infect Dis 1991; 10: 728-34.
11. Wilcox MH, Winstanley TG, Douglas CWI, Spencer RC. Susceptibility of α-haemolytic streptococci causing endocarditis to benzylpenicillin and 10 cephalosporins. J Antimicrob Chemother 1993; 32: 63-9.
12. Dyson C, Barnes RA, Harrison GAJ. Infective endocarditis: an epidemiological review of 128 episodes. J Infect 1999; 38: 87-93.
13. Elting LS, Bodey GP, Keefe BH. Septicaemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14: 1201-7.
14. Bochud P-Y, Calandra T, Francioli P. Bacteraemia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256-64.
15. Working Party of the British Society for Antimicrobial Chemotherapy Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. Heart 1998; 79: 207-10.
16. Lonks JR, Dickinson BP, Runarsdottir V. Endocarditis due to Streptococcus mitis with high level resistance to penicillin and cefotaxime. NEJM 1999; 341: 1239.
17. Levitz RE. Prosthetic valve endocarditis caused by penicillin-resistant Streptococcus mitis. NEJM 1999; 340: 4.
18. Rosser SJ, Alfa MJ, Hoban S, Kennedy J, Harding GK. E-test vs agar dilution for antimicrobial susceptibility testing of viridans group streptococci. J Clin Micro 1999; 37: 26-30.
19. BSAC disc diffusion method for antimicrobial susceptibility testing. Version 2.1.4 May 2003. www.BSAC.org.uk
20. Tuohy M, Washington JA. Antimicrobial susceptibility of viridans group streptococci. Diag Microb Infect Dis 1997; 29: 277-80.
21. Guiot HFL, Corel LJA, Vossen JMJ. Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders. Euro J Clin Microbiol Infect Dis 1994; 13: 645-50.
22. Hashemi FB, Schutze GE, Mason ER. Discrepancies between results by E-tests and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J Clin Micro 1996; 34: 1546-7.
23. Perry JD, Jones AL, Gould FK. Glycopeptide tolerance in bacteria causing endocarditis. J Antimicrob Chemother 1999; 44: 121-4.
24. Rolston KVI, Elting LS, Bodey GP. Bacteraemia due to viridans group streptococci in neutropenic patients. Am J Med 1995; 99: 450.
25. Noval R, Henriques B, Charpentier E, Normark S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999; 399: 590-3.